Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Gems #84
Wednesday 1 August 2018, 01:00 AM
“Rivaroxaban (a DOAC) fully funded from 1 August.”
Rivaroxaban is a direct-acting oral anticoagulant (DOAC), generally used for the prevention of atrial fibrillation-related stroke and venous thromboem
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References